Knowledge is power. Are you facing a new diagnosis or recurrence of Gastric Cancer? The GI Connection Gastric Cancer Information Center has current, evidence-based information for you. Get the facts about the prevention, treatment, and living with Gastric Cancer. Stay up to date with news, tips, and features designed to keep you informed about the most recent developments and advances. learn more about Gastric Cancer
You are not alone—The GI Connection Community is the leading Social Media Application for individuals seeking information, inspiration, and support. With over 50,000 members the network offers patients and caregivers a thriving community to support the many ongoing needs. Login or register here.
March 8, 2019
The United States Food and Drug Administration (FDA) has approved Lonsurf® (trifluridine/tipiracil)) as a treatment for adult patients with metastatic gastric […]
Tags: Gastric Cancer, News Tips and Features, News Tips and Features Other
December 21, 2017
Diagnosed with Gastric Cancer: 10 Tips on How to Get The Most From Your Doctor
1) Choose Your Doctor Carefully Surgeons, medical oncologists and radiation oncologists are the primary doctors involved with gastric cancer and […]
Tags: Gastric Cancer, News Tips and Features, News Tips and Features Other
November 27, 2017
The use of a proton-pump inhibitor (PPI) medication after Helicobacter pylori eradication appears to more than doubles the risk for developing gastric […]
Tags: esomeprazole, Gastric Cancer, gastric Ulcer, heliobacter pylori, lansoprazole, News Tips and Features, News Tips and Features Other, Nexium, omeprazole, Prevacid, Prilosec, proton pump inhibitors
October 3, 2017
New Standard of Care for Treatment of Resectable Gastric Cancer
The superiority of docetaxel based triplet therapy over standard care in patients with resectable esophago-gastric cancer has been confirmed in […]
Tags: Esophageal Cancer, esophago-gastric cancer, Gastric Cancer, News Tips and Features, News Tips and Features Other
September 25, 2017
Keytruda (Pembrolizumab) is now indicated for patients with recurrent locally advanced or metastatic gastric or gastro-esophogeal junction adenocarcinoma. Patients eligible […]
Tags: checkpoint inhibitor, Esophageal Cancer, Gastric Cancer, gastro-esophogeal junction cancer, keytruda, metastatic gastric, News Tips and Features, News Tips and Features Other, pembrolizumab, Precision Cancer Medicine
September 18, 2017
Keytruda Immunotherapy Appears Promising in Advanced Gastric Cancer
Keytruda (pembrolizumab) appears promising in patients with pretreated metastatic gastric cancer, according to late-breaking results from the KEYNOTE-059 trial presented […]
Tags: Gastric Cancer, immunotherapy, KEYNOTE-059 programmed death-ligand 1, keytruda, metastatic gastric cancer, News Tips and Features, News Tips and Features Other, PD-L1, pembrolizumab, Precision Cancer Medicine, stomach cancer
February 9, 2017
Interim PET Scans May Improve Treatment for Esophageal Cancer
Clinical trial results presented at the 2017 Gastrointestinal Cancers Symposium in San Francisco suggest that the use of PET scans […]
Tags: Esophageal Cancer, Gastric Cancer, News Tips and Features, News Tips and Features Other
 |
 |
 |
